1 / 9

Vigilance guidance for specific devices Tony Sant/Andy Crosbie – MHRA

Vigilance guidance for specific devices Tony Sant/Andy Crosbie – MHRA. Presentation to the closed session of the Expert Group on Vigilance for Medical Devices – 15 Nov 2012. Background. MHRA has for some years issued advice on vigilance reporting for specific types of devices.

cree
Télécharger la présentation

Vigilance guidance for specific devices Tony Sant/Andy Crosbie – MHRA

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Vigilance guidance for specific devicesTony Sant/Andy Crosbie – MHRA Presentation to the closed session of the Expert Group on Vigilance for Medical Devices – 15 Nov 2012

  2. Background • MHRA has for some years issued advice on vigilance reporting for specific types of devices. • Guidance is aimed at manufacturers and gives advice on notifying the MHRA of adverse incidents involving specific types of CE-marked medical devices under the medical devices vigilance system. • Guidance is intended to facilitate uniform application and implementation of Medical Devices Directive 93/42/EEC. It is supplementary to (and should be read in conjunction with) the latest version of European Commission Guidelines on the Medical Devices Vigilance System - MEDDEV 2.12-1

  3. UK device specific vigilance guidance • VG 01 Joint replacement implants - July 2010 • VG 02 Artificial heart valves - Nov 2008 • VG 03 Breast implants - Oct 2009 • VG 04 Coronary stents - Mar 2009 • VG 05 IVD blood glucose meters for POCT or home use - Dec 2008 • VG 06 Inferior vena cava (IVC) filters - Mar 2009 • VG 07 Intra-ocular lenses - Jun 2009 • VG 08 Neurostimulators - Dec 2009 • VG 09 Cardiac Ablation Catheters - July 2010 See: http://www.mhra.gov.uk/Publications/Regulatoryguidance/Devices/ Vigilanceguidanceforspecificdevices/index.htm

  4. What do the device specific vigilance guidance documents do? • They provide technical / clinical detail to supplement the general guidance on vigilance reporting given in MEDDEV 2.12-1 • Each MHRA guidance document lists the major recognised types of adverse incident associated with each specific type of medical device and then gives MHRA’s opinion on whether it is or is not usually reportable under vigilance as a “malfunction or deterioration in the characteristics and/or performance of the device”

  5. Reportable Complications during deployment and placement Perforation/erosion Partial or multiple fractures Device migration Progressive tilting/angulation Recurrent/fatal pulmonary embolism Retrieval difficulties Labelling deficiencies MRI induced events Unanticipated events Generally non-reportable Vascular access and device placement related problems Inferior vena cava thrombosis/occlusion Endothelialisation IVC wall penetration Infection Adverse reaction Summary table (see VG 06) of reportable/non-reportable individual adverse incidents under the vigilance system for inferior vena cava filtersNote – for illustrative purposes only, this is not an exhaustive list

  6. Periodic summary reporting and trend reports • MEDDEV 2.12-1 includes provision for manufacturers to undertake periodic summary reporting and to submit trend reports to national competent authorities • Device specific vigilance guidance can be used to provide guidance on types of adverse incidents which may be suitable for these types of reporting (see for example VG 04 on coronary stents)

  7. Why should European device specific vigilance guidance be developed? • Device specific vigilance guidance would • supplement the general guidance in MEDDEV 2.12-1 on a Europe-wide basis • Improve co-ordination of advice to industry and prepare for centralised reporting • Harmonise use of PSRs and Trend reports in specific areas • Minimise effort by concentrating on the lists of incident types to report and not to report and when to use Trend and PSR reports • The Commission and Member States are expected to improve co-ordination (Dalli immediate action plan) • Now that the MD Regulations have been proposed (Sept 2012) a simple programme of development could begin

  8. Next steps Propose • Vigilance MDEG discusses and agrees 1 or 2 device specific guidance documents per meeting

  9. Thanks for listening

More Related